›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:GeneseeqPrime™
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
GeneseeqType:
CE Marked
Related tests:
GeneseeqPrime™ analyzes 437 cancer-related genes by next-generation sequencing. It reveals clinically actionable information for therapy selection by providing valuable insight into key oncogenic genes and drug resistance mechanisms. Identifies numerous mutation types: single nucleotide variants (SNVs), insertions and deletions (indels), copy number variations (CNVs), gene fusions and large genomic rearrangements (LGR). Assesses key biomarkers: tumor mutation burden (TMB), microsatellite instability (MSI), DNA mismatch repair (MMR) genes, homologous recombination repair (HRR) genes.
Cancer:
Lung Cancer, Solid Tumor
Gene:
HRD (Homologous Recombination Deficiency), MSI (Microsatellite instability), TMB (Tumor Mutational Burden)
HRD (Homologous Recombination Deficiency), MSI (Microsatellite instability), TMB (Tumor Mutational Burden)
Method:
Next-Generation Sequencing (NGS)
